Search Results

There are 5798 results for: content related to: Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma

  1. You have free access to this content
    Colorectal cancer and RASSF family—A special emphasis on RASSF1A

    International Journal of Cancer

    Volume 132, Issue 2, 15 January 2013, Pages: 251–258, Maria Sofia Fernandes, Fátima Carneiro, Carla Oliveira and Raquel Seruca

    Article first published online : 14 JUL 2012, DOI: 10.1002/ijc.27696

  2. Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells

    Molecular Carcinogenesis

    Volume 50, Issue 11, November 2011, Pages: 901–912, Ismaël Hervé Koumakpayi, Cécile Le Page, Nathalie Delvoye, Fred Saad and Anne-Marie Mes-Masson

    Article first published online : 22 MAR 2011, DOI: 10.1002/mc.20766

  3. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling

    Molecular Carcinogenesis

    Volume 49, Issue 10, October 2010, Pages: 902–912, Gagan Deep, Subhash C. Gangar, Nicholas H. Oberlies, David J. Kroll and Rajesh Agarwal

    Article first published online : 18 AUG 2010, DOI: 10.1002/mc.20670

  4. You have free access to this content
    Translational Science

    BJU International

    Volume 112, Issue S1, August 2013, Pages: 30–53,

    Article first published online : 18 JUL 2013, DOI: 10.1111/bju.12293

  5. 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors

    The Prostate

    Volume 70, Issue 11, 1 August 2010, Pages: 1166–1178, Giovanni Luca Gravina, Francesco Marampon, Mario Di Staso, Pierluigi Bonfili, Alessandro Vitturini, Emmanuele A. Jannini, Richard G. Pestell, Vincenzo Tombolini and Claudio Festuccia

    Article first published online : 23 MAR 2010, DOI: 10.1002/pros.21151

  6. Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor

    Pediatric Blood & Cancer

    Volume 59, Issue 3, September 2012, Pages: 499–505, Junjiro Ohshima, Masayuki Haruta, Yuiko Fujiwara, Naoki Watanabe, Yasuhito Arai, Tadashi Ariga, Hajime Okita, Tsugumichi Koshinaga, Takaharu Oue, Shiro Hinotsu, Hisaya Nakadate, Hiroshi Horie, Masahiro Fukuzawa and Yasuhiko Kaneko

    Article first published online : 27 MAR 2012, DOI: 10.1002/pbc.24093

  7. Over-expression of IκB-kinase-ε (IKKε/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines

    The Prostate

    Volume 69, Issue 7, 15 May 2009, Pages: 706–718, Benjamin Péant, Jean-Simon Diallo, Florent Dufour, Cécile Le Page, Nathalie Delvoye, Fred Saad and Anne-Marie Mes-Masson

    Article first published online : 23 JAN 2009, DOI: 10.1002/pros.20912

  8. Modulation of β-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53

    The Prostate

    Volume 67, Issue 16, 1 December 2007, Pages: 1751–1760, Alexandra Prowald, Marcus V. Cronauer, Christoph von Klot, Tyark Eilers, Ludwig Rinnab, Thomas Herrmann, Klaus-Dieter Spindler, Mathias Montenarh, Udo Jonas and Martin Burchardt

    Article first published online : 10 OCT 2007, DOI: 10.1002/pros.20660

  9. You have free access to this content
    Ras-Association Domain Family 1 Protein, RASSF1C, Is an IGFBP-5 Binding Partner and a Potential Regulator of Osteoblast Cell Proliferation

    Journal of Bone and Mineral Research

    Volume 20, Issue 8, August 2005, Pages: 1430–1439, Yousef G Amaar, David J Baylink and Subburaman Mohan

    Article first published online : 14 MAR 2005, DOI: 10.1359/JBMR.050311

  10. Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells

    The Prostate

    Volume 72, Issue 4, March 2012, Pages: 450–460, Lynn N. Thomas, Timothy J. Morehouse and Catherine K.L. Too

    Article first published online : 17 JUN 2011, DOI: 10.1002/pros.21446

  11. Alterations of RASSF1A in premalignant cervical lesions: Clinical and prognostic significance

    Molecular Carcinogenesis

    Volume 51, Issue 9, September 2012, Pages: 723–733, Sraboni Mitra, Dipanjana Mazumder (Indra), Partha S. Basu, Ranajit K. Mondal, Anup Roy, Susanta Roychoudhury and Chinmay K. Panda

    Article first published online : 1 AUG 2011, DOI: 10.1002/mc.20837

  12. You have free access to this content
    The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2–DAXX–HAUSP complex

    The EMBO Journal

    Volume 27, Issue 13, July 9, 2008, Pages: 1863–1874, Min Sup Song, Su Jung Song, So Yeon Kim, Hyun Jung Oh and Dae-Sik Lim

    Article first published online : 19 JUN 2008, DOI: 10.1038/emboj.2008.115

  13. You have free access to this content
    Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation

    The EMBO Journal

    Volume 25, Issue 14, July 26, 2006, Pages: 3286–3297, Daiju Kitagawa, Hiroaki Kajiho, Takahiro Negishi, Seiji Ura, Tomomi Watanabe, Teiji Wada, Hidenori Ichijo, Toshiaki Katada and Hiroshi Nishina

    Article first published online : 29 JUN 2006, DOI: 10.1038/sj.emboj.7601212

  14. Inhibition of glycogen synthase kinase-3β promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines

    Journal of Cellular Biochemistry

    Volume 109, Issue 6, 15 April 2010, Pages: 1192–1200, Stefanie V. Schütz, Marcus V. Cronauer and Ludwig Rinnab

    Article first published online : 1 FEB 2010, DOI: 10.1002/jcb.22500

  15. Fgf10 expression patterns in the developing chick inner ear

    Journal of Comparative Neurology

    Volume 521, Issue 5, 1 April 2013, Pages: 1136–1164, Luis Óscar Sánchez-Guardado, Luis Puelles and Matías Hidalgo-Sánchez

    Article first published online : 29 JAN 2013, DOI: 10.1002/cne.23224

  16. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants

    The Prostate

    Volume 73, Issue 10, July 2013, Pages: 1017–1027, Laura R. Bohrer, Ping Liu, Jian Zhong, Yunqian Pan, James Angstman, Lucas J. Brand, Scott M. Dehm and Haojie Huang

    Article first published online : 6 FEB 2013, DOI: 10.1002/pros.22649

  17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 9, September 2008, Pages: 1448–1458, Wan-Jiang Xue, Chun Li, Xiao-Jun Zhou, Hong-Geng Guan, Lei Qin, Peng Li, Zhi-Wei Wang and Hai-Xin Qian

    Article first published online : 6 AUG 2007, DOI: 10.1111/j.1440-1746.2007.05067.x

  18. You have free access to this content
    RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer

    International Journal of Cancer

    Volume 115, Issue 4, 1 July 2005, Pages: 575–581, Naeyun Choi, Dae-Soon Son, Inseung Song, Hye-Sook Lee, Yoo-Sung Lim, Min Sup Song, Dae-Sik Lim, Jinseon Lee, Hojoong Kim and Jhingook Kim

    Article first published online : 7 FEB 2005, DOI: 10.1002/ijc.20916

  19. You have free access to this content
    Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand

    International Journal of Cancer

    Volume 131, Issue 5, 1 September 2012, Pages: E614–E624, Raphael Rutkowski, Inga Mertens-Walker, Jessica E. Lisle, Adrian C. Herington and Sally-Anne Stephenson

    Article first published online : 11 JAN 2012, DOI: 10.1002/ijc.27392

  20. You have free access to this content
    Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

    International Journal of Cancer

    Volume 109, Issue 3, 10 April 2004, Pages: 377–384, Julia Reifenberger, Christiane B. Knobbe, Astrid A. Sterzinger, Britta Blaschke, Klaus W. Schulte, Thomas Ruzicka and Guido Reifenberger

    Article first published online : 9 JAN 2004, DOI: 10.1002/ijc.11722